AGP Executive Report
Last update: 25 minutes agoEbola Drug Trial Push (Africa): Mauritius-headquartered Xylomed Pharmaceuticals says it’s preparing a double-blind, randomised clinical trial for an experimental Ebola therapeutic, targeting DRC, Uganda and South Sudan, after lab work suggested the medicine can stop the virus from replicating. Microplastics Monitoring (Regional Health): Scientists from 21 African countries met in Accra to harmonise coastal microplastics monitoring protocols using nuclear and isotopic techniques, aiming for comparable data to guide evidence-based environmental and health policies. Local Talent Spotlight (Mauritius): Namibian healthcare student Maxine “Magano” Nauyala, studying at Polytechnic Mauritius, is building an international modelling profile while competing in Mauritius Model of the Month. Governance & Health System Risk (Mauritius): An opinion piece flags Mauritius’ pension reform delays and policy reversals as a wider governance problem that could strain welfare planning. Clean Energy With Health Links (Mauritius ties): Aditya Birla Group’s planned acquisition of Shell’s Mauritius-based Sprng Energy holding company expands a renewable portfolio of about 5 GWp, with potential long-term public health benefits via cleaner power.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
